Moffitt Offers Breakthrough Therapy for Leptomeningeal Disease

Behind the Science is a video series featuring Moffitt Cancer Center clinicians and researchers spearheading novel therapies and groundbreaking treatments. You’ll get an up-close look at the innovative research being conducted every day.

Moffitt is offering a unique trial for leptomeningeal disease, which is when tumor cells infiltrate the fluid spaces of your brain and can go all over the brain and up and down the spinal cord. It’s very difficult to treat. Moffitt is the first and only place offering a breakthrough therapy to stimulate the body’s immune system. Dr. Peter Forsyth shares more with Dr. Patrick Hwu in the latest Behind the Science.

In mice, it looks like it might prevent it once you treat it. So it’s kind of a secondary prevention.

Dr. Peter Forsyth, Chair, Department of Neuro-Oncology